Navigation Links
Historic Seed Delivery Made in Illinois for First New Soybean Varieties With the Greater Yield Potential of Roundup Ready 2 Yield(TM)

ST. LOUIS, Feb. 4 /PRNewswire-FirstCall/ -- Illinois, a state that hosted the first field trial of biotechnology crops more than two decades ago, made history again this week with the first delivery to a dealer of the next generation of higher yielding soybean technology. The technology, Monsanto's Roundup Ready 2 Yield(TM) soybean trait, is expected to be the platform for Monsanto's new soybean technologies in the coming decade.


Soybean and corn farmer Allen Pfeiffer of Bonfield, Ill., received the first delivery of soybeans with the Roundup Ready 2 Yield trait at his Asgrow dealer, Heritage FS Inc., in Herscher, Ill. Asgrow, Monsanto's national soybean seed brand, is one of the first seed companies to market the new higher-yielding soybean technology.

Pfeiffer is transitioning to be the next generation to run the family farming operation, and looks forward to experiencing the next-generation of soybean technology.

"It's exciting to be keeping up with technology and improving my farm," he said. "Talking to my local seed dealer and hearing about the plot data helped me make my decision to try Asgrow Roundup Ready 2 Yield. The whole idea is to help our bottom line." The brand's consistency and seed quality were also factors in his seed purchase decision.

"As the seed brand that delivers innovation to the farm, Asgrow is proud to be leading the way in the introduction of this important new technology," said Asgrow Marketing Lead Jeff Wheeler. "The combination of Roundup Ready 2 Yield's step-change in yield potential and the consistent, high performance of Asgrow's exclusive genetics is a winning combination in the field."

Roundup Ready 2 Yield offers farmers the same flexible, dependable weed control and crop safety as original Roundup Ready soybeans, but with higher yield potential resulting from advanced gene mapping and insertion technology. The technology provides higher yields by producing more beans per pod on the plant. Roundup Ready 2 Yield soybeans are the next generation of the popular Roundup Ready(R) technology farmers have used in soybeans since 1996.

"Continued delivery of new technologies, such as Roundup Ready 2 Yield, to increase the productivity of Illinois soybean farmers is critical for keeping us among the most productive farmers in the world," said Illinois Soybean Association Vice Chairman Ron Moore. "We are excited and energized that Illinois is at the forefront of delivering innovation to U.S. agriculture."

Monsanto's Roundup Ready 2 Yield soybeans will be introduced as part of a controlled commercial release on 1 million to 2 million U.S. acres this year. In 2010, the trait is expected to be planted on 5 million to 6 million U.S. acres across a broader spectrum of maturity groups.

For additional information about the delivery, please visit

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit:

Monsanto Company is a member of BIO's Excellence Through Stewardship(SM) (ETS) Initiative. This product will be commercialized in compliance with the ETS and Monsanto Product Launch Stewardship policies, after meeting applicable regulatory requirements in key export markets with functioning regulatory systems. Any crop or material produced from this product can only be exported to, or used, processed or sold in countries where all necessary regulatory approvals have been granted. It is a violation of national and international law to move material containing biotech traits across boundaries into nations where import is not permitted. Monsanto encourages growers to talk to their grain handler to confirm their buying position for this product. Excellence Through Stewardship(SM) is a service mark of Biotechnology Industry Organization. ALWAYS READ AND FOLLOW PESTICIDE LABEL DIRECTIONS. Roundup Ready(R) crops contain genes that confer tolerance to glyphosate, the active ingredient in Roundup(R) agricultural herbicides. Roundup(R) agricultural herbicides will kill crops that are not tolerant to glyphosate. Roundup Ready 2 Yield(TM) is a trademark of Monsanto Technology LLC. (C)2009 Monsanto Company.

Media: Ben Kampelman (314-694-6192)

SOURCE Monsanto Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. African Ancestry, Educators, Identity Experts Launch DNA Education Project during Historic Black History Month; 7th Graders Score High on Ultimate Self Test
2. Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama
3. Campus Celebrates Historic Milestone
4. ABMAC Foundation Announces Publication of an Historic Volume Documenting the Creation of a National Health Care System in Taiwan
5. A Communitys Fight to Preserve its Historical and Rural Culture in Virginia: Biotechnology CEO Gets Involved
6. Historic Breakthrough in Fighting Childrens Batten Disease as China Stem Cells Give New Lease on Life to 6 Year Old California Boy
7. NanoLogix Inc. Announces Historical First in Energy Generation With Bioreactor-Produced Hydrogen at Welchs
8. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
9. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
10. Probiotic Delivery Technology Awarded Third International Patent
11. MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies
Post Your Comments:
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
Breaking Biology News(10 mins):